SCHEMBL2568640

SCHEMBL2568640

CCCCn1cc(NC(=O)Nc2ccc(Cl)cc2C)nc1OC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
SLC6A3 Q01959 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
POLB P06746 3/20 0.37
TP53 P04637 1/20 0.37
IDH1 O75874 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
GBA1 P04062 1/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569125 0.89 MAPT (0.39) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL1595904 0.86 MAPT (0.42) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL2572026 0.85 P2RX7 (0.48) MAPTSMN1; SMN2KMT2APOLBTP53
SCHEMBL2565938 0.85 ALOX5 (0.40) MAPTSMN1; SMN2RAB9ANPC1POLB
SCHEMBL2572466 0.84 MAPK1 (0.37) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL2570520 0.84 MEN1 (0.39) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL2570875 0.84 MAPK1 (0.37) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL2567127 0.81 GRIK1 (0.42) MAPTRAB9AMEN1KMT2ATP53
SCHEMBL13197811 0.78 EPHX2 (0.38) MAPTSMN1; SMN2RAB9ANPC1SLC6A3
SCHEMBL2569122 0.77 MAPT (0.40) MAPTSMN1; SMN2RAB9ANPC1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732901-B1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND AICURIS GMBH & CO KG (DE) 2011-11-02 EP disclosed
EP-1853582-B1 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO KG (DE) 2009-10-21 EP disclosed
EP-1732901-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND Bayer HealthCare AG (DE) 2006-12-20 EP disclosed
WO-2005092865-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND BAYER HEALTHCARE AG (DE) 2005-10-06 WO disclosed